"10.1371_journal.pmed.1001280","plos medicine","2012-08-07T00:00:00Z","Aaron S Kesselheim; Bo Wang; David M Studdert; Jerry Avorn","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Schools of Law and Population Health, University of Melbourne, Melbourne, Australia","Conceived and designed the experiments: ASK DMS JA. Performed the experiments: ASK BW. Analyzed the data: ASK BW. Wrote the first draft of the manuscript: ASK BW. Contributed to the writing of the manuscript: ASK BW DMS JA. ICMJE criteria for authorship read and met: ASK BW DMS JA. Agree with manuscript results and conclusions: ASK BW DMS JA.","The authors have declared the following competing interests: ASK was co-chair of a conference entitled Conflicts of Interest in the Practice of Medicine: A National Symposium sponsored by the American Society of Law, Medicine, and Ethics, the Highmark Foundation, the Jewish Healthcare Foundation, and the University of Pittsburgh; ASK was paid a small honorarium for his effort. In 2008-2009, ASK served as an expert witness for the state of Texas in a case against Merck alleging inappropriate promotion of rofecoxib (Vioxx), and ASK served as an expert witness for a class of individual plaintiffs in a case against AstraZeneca alleging inappropriate promotion of esomeprazole (Nexium). All other authors have declared no competing interests.","2012","08","Aaron S Kesselheim","ASK",4,FALSE,3,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
